Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUBIPROSTONE vs LUMASIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUBIPROSTONE vs LUMASIRAN: Safety Overview

Metric LUBIPROSTONE LUMASIRAN
Total FAERS Reports 1,214 279
Deaths Reported 118 15
Death Rate 9.7% 5.4%
Hospitalizations 332 99
Average Patient Age 64.0 yrs 43.3 yrs
% Female Patients 66.5% 72.7%
FDA Approval Date Apr 29, 2008 Nov 23, 2020
Manufacturer Direct_Rx Alnylam Pharmaceuticals, Inc.
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription